Abstract-The NCRP 156 wound model was heavily based on data from animal experiments. The authors of the report acknowledged this limitation and encouraged validation of the models using data from human wound exposures. The objective of this paper was to apply the NCRP 156 wound models to the bioassay data from four plutonium-contaminated wound cases reported in the literature. Because a wide variety of forms of plutonium can be expected at a nuclear facility, a combination of the wound models-rather than a single model-was used to successfully explain both the urinary excretion data and wound retention data in three cases. The data for the fourth case could not be explained by any combination of the default wound models. While this may possibly be attributed to the existence of a category of plutonium whose solubility and chemistry are different than those described by the NCRP 156 default categories, the differences may also be the result of differences in systemic biokinetics. The concept of using a combination of biokinetic models may be extended to inhalation exposures as well, where more than one form of radionuclide-particles of different solubility or different sizes-may exist in a workplace. Health Phys. 113(3): 209-219; 2017 
INTRODUCTION
RADIOACTIVE MATERIALS enter the human body through different pathways: ingestion, inhalation, injection, wound, and absorption through skin. Inhalation is a common pathway of intake in occupational scenarios and is particularly important for workers involved in nuclear fuel production or reprocessing (Watts 1975) . Ingestion is a significant pathway for public exposures due to consumption of contaminated food and water. The biokinetics and dosimetry of one form of intake are inherently different than that of the other form. Because of the importance of the inhalation and ingestion pathways in public or occupational contexts, consensus biokinetic and dosimetric models for these pathways have been in development, revision, and modification for several decades (e.g., International Commission on Radiological Protection, 1979 Protection, , 1994 Protection, , 2006 . Intake via wound pathways, although not as common as the inhalation pathways in the workplace, can be a significant contributor to intakes, particularly in the nuclear industry. Historically, most wound cases were analyzed either assuming injection (direct input into the blood) or by empirically representing the kinetics of systemic uptake through a system of multi-exponentials (e.g., LaBone, 2005; Falk et al. 2006) . Although more than 2,100 cases were reported in the literature (Ilyin 2001) , no consensus biokinetic and dosimetric model existed for analysis of wound cases until the publication of NCRP Report No. 156 (NCRP 2006) .
The NCRP 156 wound model is a relatively recent addition to the current family of biokinetic models developed for various types of intakes. The wound model, created using a mechanistic framework of biochemical principles, includes the transfer rates between the compartments that reflect the time-dependent nature of radionuclide absorption into the blood (Guilmette and Durbin 2003; NCRP 2006) . The data that contributed to the development of the model was heavily based on animal experiments, and hence the authors of the report acknowledged that the models need to be applied to human cases involving contaminated wounds for further validation (Guilmette et al. 2007) . Previous attempts to validate the NCRP 156 models using the biokinetic data from the nonhuman primates (NHPs) were problematic primarily because the chemical forms of radioactive materials used in the NHP experiments (e.g., Am-citrate complex) had different solubility and physico-chemistry than those from which the NCRP models were developed [e.g., AmCl 3 , Am(NO 3 ) 3 ]. Moreover, the differences in the systemic kinetics of the NHPs and humans also introduced a confounding effect on the validation attempts (Poudel et al. 2016 (Poudel et al. , 2017a . This necessitated that the NCRP 156 wound model be verified based on human occupational data. The objective of this paper was to apply the NCRP 156 wound models to the urinary excretion and wound retention data from accidental wound exposures in humans.
DATA
A major challenge when developing or validating a biokinetic model for wound exposures in humans is that most documented wound cases (e.g., Schofield et al. 1974; Carbaugh et al. 1989; Hall et al. 1978; Bailey et al. 2003; Fritsch et al. 2007; Bertelli et al. 2010; Schadilov et al. 2010) involve treatment with DTPA (diethylenetriaminepenta-acetic acid). Since the DTPA binds to plutonium and increases the excretion rate via urine, the data from such cases cannot be used to validate the models for unperturbed exposures. Moreover, the data from occupational wound cases are usually confounded by other forms of intakes, such as inhalation or multiple wounds (e.g., James et al. 2007) . So, the biokinetic data from wound exposures-that are not perturbed or confounded-in open literature is very scant.
One of the most important sources of well-documented data on wound cases comes from the Former Radiation Worker Medical Surveillance Program (Falk et al. 2006) . The paper reports case descriptions and long-term urinary excretion results for five plutonium-contaminated wound cases that occurred at the Rocky Flats Plant. In addition to these cases, a few other wound cases also exist in the literature, and these have been compiled in the IDEAS Internal Contamination Database (Hurtgen et al. 2007; IDEAS 2007) . However, since the detailed description of the cases were not available, the cases described in Falk et al. (2006) formed the basis of this analysis. Because the paper was published before the development of NCRP Report No. 156, the authors used three other approaches (discussed later) to analyze the urinary excretion data from these cases. Case 502, one of the cases described in Falk et al. (2006) , was not included in this analysis to avoid confounding due to multiple excisions, with one occurring at almost a year after the intake. The detailed case descriptions of the wound cases discussed in this paper are given in Falk et al. (2006) , but the cases have been briefly discussed in Table 1 for completeness.
BIOKINETIC MODELS AND MODEL CALCULATIONS
The generic wound model described in NCRP 156 is given in Fig. 1 (labeled "WOUND") . The model consists of five compartments: Soluble; Colloid and Intermediate States (CIS); Particles, Aggregates and Bound States (PABS); Trapped Particles and Aggregates (TPA) and Fragments, which were conceived in order to describe the behavior of both soluble and insoluble radioactive materials regardless of the initial physical and chemical state. The radioactive materials may be contained in the compartments in their original states or may undergo changes and move from one compartment to another (NCRP 2006; Doerfel et al. 2012) .
The category "soluble" is further divided into retention classes of weak, moderate, strong and avid categories depending on the solubility of the contaminating material. Materials introduced into the wound initially in a soluble form enter the soluble compartment. A fraction of this activity would be absorbed into the blood compartment, and the remaining activity enters the CIS compartment. The transfer of radionuclides to the CIS compartment is governed by the tendency of the aqueous solution chemistry of the radioactive material. Particularly for polyvalent actinides and lanthanides, the tendency of the radioactive material to hydrolyze eventually determines the retention of the material at the wound site. A fraction of the activity in the CIS compartment will be transformed into bound states in the PABS compartment. Material in CIS and PABS compartments solubilize and transfer back into the soluble compartments, albeit very slowly. A fraction of the activity in the CIS and PABS compartment is transferred to the lymph nodes, which represents long-term retention at or near the wound (NCRP 2006) . Table 1 . Description of wound cases discussed in this paper (Falk et al. 2006 Particulate radionuclides, based on their physical properties and retention pattern, have been grouped into three main categories: colloid, particle, and fragment. Colloids are formed as hydrolysis products and have particulate properties. Fragments and particulates are solids, which include pure materials such as plutonium metals or oxides, mixtures such as mixed oxides or metal alloys, or solid materials contaminated on their surface with soluble radionuclides. The particle category represents material whose individual particulates are ≤20 mm in physical size. The fragment category comprises larger particles and fragments whose sizes or quantities cause foreign body reactions in the tissue. The particulate materials have a much longer retention in the wound compared to soluble materials, primarily due to the insolubility of the materials and the potential for foreign-body encapsulation (National Council on Radiation Protection and Measurements, 2006; Castellani et al. 2013) .
First-order kinetics are used to describe the transfer of material from one compartment to another. The transfer rates between the compartments for various pathways for various types of materials are given in Table 2 .
The NCRP wound model can be combined with the systemic model (e.g., Leggett et al. 2005 ) via the blood compartment, which serves as a final clearance compartment from the wound model and as a transfer compartment for the systemic model. In the systemic model, the blood compartment is connected to soft tissues, skeleton, liver, kidneys, urinary bladder and the alimentary canal, each of which is represented by one or more compartments (Fig. 1) . The transfer between the compartments is also characterized by first order kinetics, and the default transfer rates are given in Leggett et al. (2005) .
The compartmental calculations were completed using a method described by Birchall and James (1989) . This method involves starting with a rate matrix [R] , which is converted into matrix [A] by replacing the diagonal elements of each row of [R] with the negative of the sum of transfer rates in that row and the decay constant, and then transposing the matrix. The matrix [A] can then be used to calculate the quantities in each compartment at time t:
If x(0) is the column vector representing the initial amount in each compartment, the instantaneous amount in each compartment i at time t, x(t) is then the ith element of the matrix:
UEF(t), the expected urinary excretion rate per day at time t, is the difference between the content in the "urine compartment" (say jth compartment) in day t and that in day t−1; i.e., the jth element of the following matrix:
The urinary excretion calculations were verified using the internal dosimetry software package Activity and Internal Dose Estimates (AIDE) (Bertelli et al. 2008 ; AIDE, Version 6.0. Santa Fe, NM). The residual activity in wounds as a fraction of intake, Wound(t), is given by the sum of the activities retained in each wound compartment at time t,; i.e.,
Wound t
ð Þ ¼ Soluble t ð Þ þ CIS t ð Þ þ PABS t ð Þ þ TPA t ð Þ þ Fragment t ð Þ:ð4Þ
ANALYSIS USING NCRP 156 WOUND MODELS
One of the most commonly used methods for fitting of the bioassay data is the maximum likelihood method (International Atomic Energy Agency, 2004; Castellani et al. 2013 ). This method, employed in several internal dosimetry programs such as Integrated Modules for Bioassay Analysis (IMBA) (Birchall et al. 2007 ) and AIDE (Bertelli et al. 2008) , minimizes the value of chi-square, given as:
and the estimate of the intake is given as (Castellani et al. 2013 ): The model for soluble radionuclides assume direct injection into the "Soluble" compartment.
b
The models for colloids, particles and fragments assume direct injection into "CIS," "PABS," and "Fragment" compartments, respectively. c Categories recommended for plutonium chemistries.
where M i is the value of the ith measurement, m(t i ) is the urinary excretion fraction associated with the ith measurement and calculated using eqn (3) above, I i is the intake calculated from the ith measurement and is given as I i = M i /m(t i ), and SF i is the scattering factor associated with the ith measurement. SF is a measure of uncertainty in the measurement data. The IDEAS Guidelines (Castellani et al. 2013) , set to establish consistency in the evaluation of internal dosimetry cases, recommend that the SF of 1.1 and 1.6 be used for true 24-h urine and simulated 24-h urine samples, respectively. However, this analysis used the SF of 3.0 for data collected before 1993 and 1.3 for those collected in 1993 and later based on the examination of the variability of the data by Falk et al. (2006) and improvements of measurement and data-recording techniques. This helps provide heavier weights to the "modern" data.
Since the actual solubility and the chemistry of the exposure materials for each case were unknown, several wound models were used in the analysis. The NCRP 156 recommends analysis using strongly retained soluble (WSS), avidly retained soluble (WSA), colloid (WCO), particles (WPA), and fragments (WFR) models for plutonium chemistries. In addition to these models, analyses were also done using injection (WIN); i.e., straight input into the blood. The results of the maximum likelihood analyses using all of these models are given in Table 3 .
Acceptable fits (χ 2 /N ≤ 1) were obtained for three of the four cases using at least one of the wound models. The least chi-squares were obtained using WSS, WSA and WCO models for cases 620, 177, and 819, respectively. The intakes estimated using the models that yielded the minimum chi-square for cases 620, 177, and 819 were 1.37 Â 10 3 Bq, 1.27 Â 10 3 Bq, and 1.04 Â 10 3 Bq, respectively. The urinary excretion data for Case 626, however, could not be explained satisfactorily by either Table 3 . Analysis of urinary excretion and wound retention data using different models. Calculated using the models for which acceptable χ 2 /N were obtained (excluding WIN for which there is no wound retention). For case 626, wound retention was estimated using the WFR model. assuming direct injection or using any of the NCRP 156 wound models combined with the Leggett's systemic Pu model. The least chi-square for Cases 626 urine data was obtained when using the WFR model, which estimated the intake to be 1.48 Â 10 5 Bq. The fraction of intake retained in wounds at various times after the incident as predicted by different NCRP 156 wound models, and calculated using eqn (4) above, is given in Fig. 2 . As seen in the figure, "soluble" plutonium is cleared rapidly from the wound. For example, the retention of "strongly retained" and "avidly retained" radionuclides at the end of 100 d is 23% and 74%, and is practically none at 10,000 d post intake. Similarly, the retention of colloidal radioactive material is approximately 84% at 100 d and 0.04% at 10,000 d post intake. In contrast, plutonium in fragment and particle forms is retained much more tenaciously-99.68% and 89.92%, respectively, at 100 d, and 96.61% and 5.06%, respectively, at 10,000 d after intake.
The residual activities in the wounds on the day of last wound counts were also estimated for cases 620, 177, and 819 using the models for which acceptable χ 2 /N were obtained (Table 4 ). As seen in the table, the predicted retention in wounds for cases 620, 177, and 819 is nearly zero and thus significantly lower than the actual residual activity measured in the wounds. These results were comparable to an analysis of USTUR Case 0262 by James et al. (2007) that predicted that only about 40% of the material deposited into the wound became systemic, and to that by Weber et al. (2012) , where the NCRP 156 wound models could accurately predict the urine bioassay data but significantly underestimated the wound/lymph node retention. For case 626, wound retention was estimated using the WFR model. Because fragments are tenaciously retained at the wound site, the residual activity in wound at day 14,339 was estimated 
ANALYSIS USING THE COMBINATION OF MODELS
The inability of a single model to describe both the urinary excretion data and the wound retention data indicated that the intake could not be exclusively described as any "pure" form but rather as a possible fractionation between different material states represented in the NCRP 156 model. Moreover, the significantly higher residual activities measured at the wound retention site indicated at least one insoluble component to the intake.
The following approach was used to determine the relative contribution of each of the NCRP 156 categories for plutonium. This approach is comparable to the method used by Los Alamos National Laboratory (LANL), where a combination of several wound models-rather than one specific model-is used to calculate intake and doses from occupational wound intakes (Bertelli et al. 2010; Poudel et al. 2017b) .
The combined urinary excretion fraction, UEF combined (t), is given as:
where k represents the type of the biokinetic model used, N is the total number of biokinetic models used, r k represents the relative contribution of the type of the material explained by the biokinetic model k, UEF k represents the urinary excretion fraction for the biokinetic model k [obtained using eqn (3) above], and
For example, if the relative contributions of the types of materials explained by the biokinetic models WSS, WSA, WCO, WPA and WFR are a, b, c, d, and e respectively,
The maximum likelihood analysis method can then be used to calculate the intake and the chi-square using equations (5) and (6), but by replacing the urinary excretion fraction m(t i ) with UEF combined (t i ) calculated in eqn (11), i.e.,
Similarly, the wound retention due to the given combination of the types of materials can be calculated using eqn (14):
where, Wound k (t) is calculated using eqn (4). Finally, the effective dose can be computed using eqn (15):
where, (DC) k is the dose per unit intake of 239 Pu of the form that is explained by the model k.
Intake, chi-square and wound-retention were calculated using all possible combinations of a, b, c, d, and e. The combinations that resulted in the least chi-square while still predicting the wound-retention within the measurement uncertainty (one standard deviation) are given in Table 4 .
The analysis of case 620 urinary excretion and wound retention data indicated that the plutonium material involved in the incident was primarily soluble (85%, strongly retained) and fragment (14%) ( Table 4 ). The intake using this combination was estimated to be 1.57 Â 10 3 Bq, which is approximately 15% more than the intake estimated using the WSS model alone (Table 5) . These results were comparable to the analysis of urinary excretion data from USTUR case 0262 -who was an engineer at the Hanford site -that indicated the predominance of plutonium in strongly soluble and fragment forms (Germann 2008; James et al. 2007) . Case 620 was a plutonium machinist, so it is reasonable to expect that the individual might be dealing with some metallic form of plutonium, which contributed to significant wound activity three decades after the intake. The urinary excretion and wound retention data for case 620 is given in Fig. 3 along with the fitted curve.
Both cases 177 and 819 were plutonium process operators. Plutonium process operations involve conversion of plutonium nitrate to purified metallic hemispheres, with several intermediary forms [e.g., Pu(III) oxalate, PuO 2 , PuF 4 , metallic Pu, etc.]. As expected, the analysis of the data for these cases indicated the existence of colloidal plutonium: 39% and 16% for case 177 and 819, respectively (Table 4 ). Other forms of plutonium for case 819 included soluble (16%, strongly retained), particulate, (45%), and fragments (23%). In addition to the colloidal form, the analysis of case 177 data indicated existence of soluble (11% strongly-retained and 37% avidly-retained) and particulate form (13%) of plutonium as well. The given combinations of the different forms of plutonium resulted in an intake of 1.42 Â 10 3 Bq for Case 177 (12% more than the intake estimated using the WSA model alone) and 1.33 Â 10 3 Bq for case 819 (28% more than the intake estimated using the WCO model alone) (Table 5) . Although the exact descriptions of the conditions under which the incidents occurred are unknown, the differences in the composition of the material involved in these two cases may be due to the differences in the exact process (e.g., "dry" vs. "wet" chemistry) the individuals were involved in. The data, along with the fitted curves for case 177 and 819, are given in Figs. 4 and 5, respectively.
It should be noted that for case 626, no combination of the wound models resulted in a credible fit to the urinary excretion data. The combination of the models reported in Table 4 is the one that resulted in the least chi-square fit to the urinary excretion data while still predicting the wound retention within the measurement uncertainty. Case 626 was also a process operator, and the analysis of the data indicated the dominance of Fig. 3 . Case 620 urine and wound data along with fitted curves obtained using combination of wound models with contributions from WSS (0.85), WCO (0.01), and WFR (0.14). The credible fit to the urinary excretion data for this case was not obtained either using a single NCRP 156 model or using a combination of the models. Fig. 4 . Case 177 urine and wound data along with fitted curves obtained using combination of wound models with contributions from WSS (0.11), WSA (0.37), WCO (0.39), and WFR (0.13).
particulate forms of plutonium (49%), similar to that for case 819. The data along with the fitted curves for case 626 are given in Fig. 6 . While the inability of the wound models to predict the urinary excretion data for Case 626 can possibly be attributed to the existence of a category of plutonium whose solubility and chemistry is different than those described by the NCRP 156 default categories, the possibility of the systemic biokinetics of plutonium in case 626 being different than those described by Leggett's model (Leggett et al. 2005 ) cannot be ruled out. For case 626, the residual activity reported nearly three decades after the incident (3,220 Bq) was more than twice what was estimated to be in the wound at day 1 (1,600 Bq) (Falk et al. 2006 ). While Falk et al. (2006) attributed the discrepancy in the wound measurements to the use of a primitive wound counter, it is also possible that Pu in the wound site got redistributed with time. Factors such as dissolution of an embedded particle or fragment, change in location in the wound site due to muscle flexion, and biological processes may affect the geometry and calibration of wound measurement (NCRP 2006) . It is possible that one or more of these factors may have caused the significant change in the detection efficiency of the L x-rays, resulting in the increase in the wound counts. Falk et al. (2006) , in their original paper, estimated the intake for the wound cases using three different approaches. These methods included: 1) the five-component exponential model derived by Durbin (Durbin et al. 1972 ) using the Langham data (Langham et al. 1980) , 2) the four-component model (Jones 1985) , which is a modification of Durbin's model by including the data for two additional Langham's subjects (Rundo et al. 1976) , and 3) the Integrated Modules for Bioassay Analysis (IMBA), which used a set of exponential terms derived by fitting the urinary excretion data obtained using the ICRP 67 model (ICRP 1993) . The intakes predicted using these methods have been compared with those predicted in this paper in Table 5 . The intakes predicted using the Durbin's model were significantly higher than those predicted using the Jones model, IMBA, and NCRP 156 wound models. As expected, the intakes estimated using the combination of the NCRP 156 models were comparable to those estimated using the IMBA models-the difference ranged from about 2% for case 620 to about 21% for case 626.
The dose coefficients due to wound intake of different forms of plutonium were provided in Toohey et al. (2011) . These values were used to calculate the effective dose coefficient for the given combination of models for each case. The effective doses incurred by each case were then computed by multiplying the effective dose coefficient with the calculated intake. The effective doses were 0.66 Sv, 0.58 Sv, 2.86 Sv, and 0.44 Sv for cases 620, 177, 626, and 819, respectively (Table 6 ).
The dosimetry issue the plutonium-contaminated wounds present is twofold. The CEDEs calculated above takes into account only the radioactive material in systemic circulation. While these values are more important from a radiation protection viewpoint (National Council on Radiation Protection and Measurements, 2006), it is important to note that these CEDEs do not include the doses to the wound itself and the surrounding tissues. The contaminated wounds may present potential harmful effects to the site from local irradiation, but the calculation of doses to the wound site is more complicated because of the lack of proper definition of volume (or mass) of the wound-site (Toohey et al. 2011) . Nevertheless, the NCRP recommends using dosimetry models for shallow (e.g., NCRP 1989 NCRP , 1999 or penetrating wounds (e.g., Stabin 1996) as applicable (NCRP 2006) .
Finally, medical management of contaminated wounds may result in significant reduction of doses. A significant fraction of the activity deposited in the wound may be removed by copious irrigation of the wound-site, or in certain cases, surgical exploration of the wound. Such surgery, which may either involve removal of the contaminant itself or removal of the contaminated tissues, results in a reduction in local dose to the wound-site and committed dose. Moreover, when the wound involves plutonium or americium, wound excisions are typically accompanied by DTPA administration, which helps to decrease the committed dose by increasing the radionuclide content in urine. A few methods for interpretation of DTPA-affected urinary excretion data were discussed in Poudel et al. (2017b) .
CONCLUSION
The biokinetic data from accidental wound exposures at Rocky Flats were analyzed using NCRP 156 model coupled with Leggett's systemic model. The urinary excretion data from three of the four cases analyzed were explained well using the NCRP 156 models; however, the models grossly underestimated the residual wound activity in the wound. A combination of the wound models-rather than a single model-was used to successfully explain both the urinary excretion and wound retention data in these three cases. The urinary excretion data for the fourth case (Case 626) could not be explained by any combination of the default wound models. While it was plausible that the case was exposed to a completely different category of plutonium and a new wound model was needed to explain the biokinetics, the differences may also be the result of differences in the systemic biokinetics. Finally, the effective doses due to wound intakes were calculated for the cases.
Wound retention data are almost never used for official intake and dose estimation purposes. However, this analysis indicated that using information on residual wound activity adds useful information about the type(s) of the material involved in a wound accident. Because a wide variety of forms of plutonium can be expected at a workplace, a combination of wound models may be required to properly explain the bioassay and wound-retention data. This concept can possibly be extended to inhalation exposures, where more than one form of radionuclides-particles of different solubility (Type F, M or S) or different sizes-may exist in a workplace. Pu for the given combination of models.
